Albendazole Completed Phase 3 Trials for Human Immunodeficiency Virus (HIV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01825031Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy